Since both cell lines exhibited metabolic disorder and overrepresentation of SLC genes common in enzalutamide resistant cells, further studies were conducted in the LNCaP enzalutamide resistant and parental counterpart. The gene discussed is CCL21; the disease is metabolic disease.